<html>
<head>
<title>D075.P.100.B.E.AP880818-0088</title>
</head>
<body bgcolor="white">
<a name="1">[1]</a> <a href="#1" id=1>Tests of Diltiazem, a calcium entry blocker, indicate that its use could prevent recurring heart attacks in a majority of patients.</a>
<a name="2">[2]</a> <a href="#2" id=2>The chance of another attack decreased 80 percent in the patients.</a>
<a name="3">[3]</a> <a href="#3" id=3>Significantly, however, the chance for a heart attack in patients with heart pumping problems increased by 25 percent.</a>
<a name="4">[4]</a> <a href="#4" id=4>This suggests that more patients will be put on the drug on a long-term basis.</a>
<a name="5">[5]</a> <a href="#5" id=5>Diltiazem is the newest in a class of drugs introduced to fight heart disease.</a>
<a name="6">[6]</a> <a href="#6" id=6>Nitrates, in use for over 50 years, and beta blockers, which were developed in the 1960s, are other treatments commonly prescribed by doctors.</a>
</body>
</html>
